Publication:
Selective activation of cardiovascular adenylate cyclase in vivo

dc.contributor.authorS. Phornchirasilpen_US
dc.contributor.authorR. Lockwooden_US
dc.contributor.otherMahidol Universityen_US
dc.date.accessioned2018-03-22T09:30:55Z
dc.date.available2018-03-22T09:30:55Z
dc.date.issued1977-01-01en_US
dc.description.abstractCyclic AMP levels were measured in cardiac and vascular tissues removed from pentobarbitone anesthetized rats pretreated with theophylline 45 mg/kg i.p. Noradrenaline, 20 μg/kg i.v., increased cardiac but not vascular cyclic AMP levels; this selective effect of noradrenaline was not altered by pretreatment with phenoxybenzamine, 1 mg/kg i.v. Tazolol, 120 μg/kg i.v., selectively increased cardiac cyclic AMP levels whereas fenoterol, 15 μg/kg i.v., selectively increased vascular cyclic AMP levels. The results suggest that adenylate cyclase activation in cardiac and vascular tissues in vivo is mediated by beta adrenoceptors which consist of different subtypes.en_US
dc.identifier.citationArchives Internationales de Pharmacodynamie et de Therapie. Vol.225, No.1 (1977), 98-103en_US
dc.identifier.issn00039780en_US
dc.identifier.other2-s2.0-0017326382en_US
dc.identifier.urihttps://repository.li.mahidol.ac.th/handle/123456789/10338
dc.rightsMahidol Universityen_US
dc.rights.holderSCOPUSen_US
dc.source.urihttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=0017326382&origin=inwarden_US
dc.subjectPharmacology, Toxicology and Pharmaceuticsen_US
dc.titleSelective activation of cardiovascular adenylate cyclase in vivoen_US
dc.typeArticleen_US
dspace.entity.typePublication
mu.datasource.scopushttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=0017326382&origin=inwarden_US

Files

Collections